Ciliary neurotrophic factor null mutation and schizophrenia in a Swedish population

被引:7
作者
Thome, J
Jonsson, E
Foley, P
Harsanyi, A
Sedvall, G
Riederer, F
机构
[1] UNIV WURZBURG, DEPT PSYCHIAT, D-97080 WURZBURG, GERMANY
[2] KAROLINSKA INST, PSYCHIAT SECT, DEPT CLIN NEUROSCI, S-17176 STOCKHOLM, SWEDEN
关键词
ciliary neurotrophic factor; genetics; genotyping; mutation; neural development; PCR; psychiatry; schizophrenia;
D O I
10.1097/00041444-199722000-00004
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
According to the maldevelopmental hypothesis, the neurotrophic factor system represents an important area which might be genetically and neurochemically involved in the etiopathogenesis of schizophrenic psychoses. Patients suffering from schizophrenic psychoses and control persons were genotyped for a null mutation of the ciliary neurotrophic factor gene. There were no significant differences in the allelic and genotypic distributions in the total schizophrenic and control samples. However, there was a negative association with a family history of psychosis. Thus, it cannot be excluded that this genetic variant represents a vulnerability marker for specific schizophrenic subtypes. The development of valid diagnostic instruments based on biological criteria is crucial for schizophrenia research; more homogenous subgroups are more likely to represent distinct nosological entities than the heterogenous group of diseases presently categorized as schizophrenia.
引用
收藏
页码:79 / 82
页数:4
相关论文
共 23 条
[1]  
AKBARIAN S, 1993, ARCH GEN PSYCHIAT, V50, P169
[2]   Failure to find associations of the CA repeat polymorphism in the first intron and the Gly(-63)/Glu(-63) polymorphism of the neurotrophin-3 gene with schizophrenia [J].
Arinami, T ;
Takekoshi, K ;
Itokawa, M ;
Hamaguchi, H ;
Toru, M .
PSYCHIATRIC GENETICS, 1996, 6 (01) :13-15
[3]  
ARNOLD SE, 1995, AM J PSYCHIAT, V152, P738
[4]  
ARNOLD SE, 1991, ARCH GEN PSYCHIAT, V48, P625
[5]   The efficacy of 2 different dosages of methylphenidate in treating adults with attention-deficit hyperactivity disorder [J].
Bouffard, R ;
Hechtman, L ;
Minde, K ;
Iaboni-Kassab, F .
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2003, 48 (08) :546-554
[6]  
Cohen J., 1988, Statistical Power Analysis for the Behavioral Sciences, V2
[7]   Maternal infectious diseases during pregnancy and obstetric complications in the etiology of distinct subtypes of schizophrenia: Further evidence from maternal hospital records [J].
Franzek, E ;
Stober, G .
EUROPEAN PSYCHIATRY, 1995, 10 (07) :326-330
[8]   NEURONAL DEVELOPMENT IN EMBRYONIC BRAIN-TISSUE DERIVED FROM SCHIZOPHRENIC WOMEN AND GRAFTED TO ANIMAL HOSTS [J].
FREEDMAN, R ;
STROMBERG, I ;
NORDSTROM, AL ;
SEIGER, A ;
OLSON, L ;
BYGDEMAN, M ;
WIESEL, FA ;
GRANHOLM, AC ;
HOFFER, BJ .
SCHIZOPHRENIA RESEARCH, 1994, 13 (03) :259-270
[9]   ASSOCIATION OF NEUROTROPHIN-3 GENE VARIANT WITH SEVERE FORMS OF SCHIZOPHRENIA [J].
HATTORI, M ;
NANKO, S .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1995, 209 (02) :513-518
[10]   PRENATAL DEVELOPMENTAL DISTURBANCES IN THE LIMBIC ALLOCORTEX IN SCHIZOPHRENICS [J].
JAKOB, H ;
BECKMANN, H .
JOURNAL OF NEURAL TRANSMISSION, 1986, 65 (3-4) :303-326